Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|11|1891-1899

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.11, 2011-11, pp. : 1891-1899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Targeting Epithelial-to-Mesenchymal Transition for Cancer Therapy)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1239-1239

Bentham Science Publishers

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1881-1890

Bentham Science Publishers

Access to resources Recommend Favorite

The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer

By  

Current Drug Targets, Vol. 11, Iss. 4, 2010-01 ,pp. : 474-481

Bentham Science Publishers

Access to resources Recommend Favorite

EDITORIAL (Thematic Issue: Emerging Roles of Epithelial-to-Mesenchymal Transition in Tumorigenesis)

By  

Current Cancer Drug Targets, Vol. 13, Iss. 9, 2013-12 ,pp. : 905-905

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

By  

Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. : 1649-1653

Bentham Science Publishers

Access to resources Recommend Favorite